# Wnt/β-Catenin Activation by iCRT3 Enhanced the Pluripotency of Bovine Expanded Pluripotent Stem Cells

**Authors:** Dongsong Liu, Burong Qu, Jing Wang, Xu Han, Mengrui Su, Xihe Li, Yao Li, Xueling Li

PMC · DOI: 10.3390/ani16040535 · Animals : an Open Access Journal from MDPI · 2026-02-09

## TL;DR

This study shows that a precise balance of Wnt/β-catenin signaling is essential for maintaining pluripotency in bovine stem cells, with a surprising synergy between iCRT3 and CHIR99021.

## Contribution

The study reveals a unique rewiring of the Wnt/β-catenin pathway in bovines and identifies a synergistic drug combination for enhancing pluripotency.

## Key findings

- Prolonged Wnt/β-catenin activation with CHIR99021 downregulates core pluripotency genes in bovine stem cells.
- Combining CHIR99021 with iCRT3 enhances pluripotency gene expression and activates Wnt/β-catenin signaling.
- The drug combination drives bEPSCs toward a hybrid naïve/formative pluripotency state.

## Abstract

Maintaining pluripotent stem cells in bovine is crucial for breeding and biotech applications but remains challenging due to unclear signaling requirements. We investigated the role of the Wnt/β-catenin pathway in bovine stem cells. Surprisingly, we found that these cells need an exact balance of Wnt/β-catenin signaling to maintain pluripotency, rather than merely simple activation or inhibition. Even more surprisingly, the combination of the classic inhibitor iCRT3 and the activator CHIR99021 produced a synergistic effect. Instead of inhibiting the pathway, combining iCRT3 with CHIR99021 appears to enhance its activity and improve stemness. Our study reveals a unique wiring of this critical pathway in bovine, providing new insights for optimizing stem cell culture systems in livestock species.

The Wnt/β-catenin signaling pathway is involved in regulating the pluripotency of mammalian stem cells. Fine-tuning of Wnt/β-catenin modulates the transition of naïve, formative or primed states with distinct lineage bias. However, its specific function in large domestic animals such as bovines remains unclear. Here we systematically investigated the role of Wnt/β-catenin signaling and its key effector TCF1 in bovine expanded pluripotent stem cells (bEPSCs) using a combination of small molecules (CHIR99021, XAV939, IWR-1, iCRT3). The results showed that prolonged Wnt/β-catenin activation with CHIR99021 induced morphological changes and downregulated the expression of core pluripotency genes POU5F1 (OCT4) and SOX2 in bEPSCs, while the existence of Wnt/β-catenin inhibitors XAV939 and IWR-1 upregulated these two genes. Knockdown of TCF1, a major nuclear effector of CTNNB1 (β-catenin), reduced the expression of pluripotency genes (POU5F1, SOX2) and key Wnt/β-catenin components (TCF3, LEF1 and CTNNB1). Combined treatment with CHIR99021 and the canonical β-catenin/TCF inhibitor iCRT3 resulted in the overactivation of Wnt/β-catenin signaling, and promoted the expression of core pluripotency genes, revealing extensive rewiring of the Wnt/β-catenin pathway in bovines. Consistent with these findings, global transcriptomics revealed that CHIR99021 combined with iCRT3 enhanced the expression of key pluripotency-related genes and further activated Wnt/β-catenin signaling target genes while simultaneously suppressing mitogenic pathways such as PI3K-Akt and MAPK signaling. Transcriptome profiling also demonstrated that this combination drives bEPSCs toward a hybrid naïve/formative pluripotency state. Together, these results demonstrate that Wnt/β-catenin signaling homeostasis is critical for bovine pluripotency regulation, which provides a foundation for refining livestock stem cell culture conditions and understanding the evolution of pluripotency networks.

## Linked entities

- **Genes:** POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460], SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657], HNF1A (HNF1 homeobox A) [NCBI Gene 6927], TCF3 (transcription factor 3) [NCBI Gene 6929], LEF1 (lymphoid enhancer binding factor 1) [NCBI Gene 51176], CTNNB1 (catenin beta 1) [NCBI Gene 1499]
- **Chemicals:** CHIR99021 (PubChem CID 9956119), XAV939 (PubChem CID 135418940), IWR-1 (PubChem CID 3137736), iCRT3 (PubChem CID 6622273)

## Full-text entities

- **Genes:** POU5F1 (POU class 5 homeobox 1) [NCBI Gene 282316] {aka OCT3, OCT4, OTF-3, oct-3, oct-4}, Pou5f1 (POU domain, class 5, transcription factor 1) [NCBI Gene 18999] {aka NF-A3, Oct-3, Oct-3/4, Oct-4, Oct3, Oct3/4}, CDX2 (caudal type homeobox 2) [NCBI Gene 618679] {aka CDX-2}, TCF3 (transcription factor 3) [NCBI Gene 530616], LIF (LIF interleukin 6 family cytokine) [NCBI Gene 280840], GFAP (glial fibrillary acidic protein) [NCBI Gene 281189], TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 515177] {aka TAZ}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 517948] {aka PI3K, PI3Kbeta}, TCF4 (transcription factor 4) [NCBI Gene 534935] {aka TCF7L2}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 535742], NANOG (Nanog homeobox) [NCBI Gene 538951], GATA4 (GATA binding protein 4) [NCBI Gene 327716], LIF (LIF interleukin 6 family cytokine) [NCBI Gene 3976] {aka CDF, DIA, HILDA, MLPLI}, AXIN2 (axin 2) [NCBI Gene 511619], GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 790875] {aka GSK3beta}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 280991] {aka AKT}, PAX6 (paired box 6) [NCBI Gene 286857] {aka pax-6}, Tcf4 (transcription factor 4) [NCBI Gene 21413] {aka 5730422P05Rik, ASP-I2, E2-2, E2.2, ITF-2, ITF-2b}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 281181] {aka GAPD}, Lef1 (lymphoid enhancer binding factor 1) [NCBI Gene 16842] {aka 3000002B05, Lef-1}, Tcf3 (transcription factor 3) [NCBI Gene 21423] {aka A1, ALF2, E12, E12/E47, E2A, E47}, LEF1 (lymphoid enhancer binding factor 1) [NCBI Gene 535399], Cdx2 (caudal type homeobox 2) [NCBI Gene 12591] {aka Cdx-2}, FGF5 (fibroblast growth factor 5) [NCBI Gene 536771] {aka FGF-5, FGF3A}, TCF12 (transcription factor 12) [NCBI Gene 509039], TCF7 (transcription factor 7) [NCBI Gene 782690], CTNNB1 (catenin beta 1) [NCBI Gene 539003], SP5 (Sp5 transcription factor) [NCBI Gene 512467], SOX2 (SRY-box transcription factor 2) [NCBI Gene 784383], Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}, Tcf7 (transcription factor 7, T cell specific) [NCBI Gene 21414] {aka TCF-1, Tcf1}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Nanog (Nanog homeobox) [NCBI Gene 71950] {aka 2410002E02Rik, ENK, Stm1, ecat4}
- **Diseases:** injury to (MESH:D014947), hepatocellular carcinoma (MESH:D006528), bEPSCM (MESH:C536038)
- **Chemicals:** oligonucleotides (MESH:D009841), SDS (MESH:D012967), Vitamin C (MESH:D001205), water (MESH:D014867), CHIR99021 (MESH:C473711), TRIzol (MESH:C411644), DPBS (MESH:C012939), F12 (MESH:C007782), Triton X-100 (MESH:D017830), Bis-Tris (MESH:C026272), streptomycin (MESH:D013307), phosphatidylinositol (MESH:D010716), K10 (MESH:D011189), DAPI (MESH:C007293), CO2 (MESH:D002245), lipid (MESH:D008055), PFA (MESH:C003043), minocycline hydrochloride (MESH:D008911), XAV939 (MESH:C544261), Alexa Fluor  488 (MESH:C000711379), A11017 (-), (S)-(+)-dimethindene maleate (MESH:D004115), penicillin (MESH:D010406)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** P0013K
- **Cell lines:** ESCs — Homo sapiens (Human), Embryonic stem cell (CVCL_UI95)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937258/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937258/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937258/full.md

---
Source: https://tomesphere.com/paper/PMC12937258